Association of peptic ulcer disease and pulmonary disease with risk of periprosthetic fracture after primary total knee arthroplasty

Arthritis Care and Research

Volumn 63, Issue 10, 2011, Pages 1471-1476

  Singh, Jasvinder A ^a,b   Lewallen, David G ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b Mayo Clinic College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; POSTOPERATIVE PERIOD; PROSTHESIS FAILURE; PROSTHESIS FIXATION; RISK FACTOR; TOTAL KNEE REPLACEMENT;

AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; COMORBIDITY; FEMALE; HUMANS; KNEE PROSTHESIS; MALE; MIDDLE AGED; MINNESOTA; PEPTIC ULCER; PERIPROSTHETIC FRACTURES; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 81255209543     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/acr.20548     Document Type: Article

References (29)

1. Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 2007;89: 780-5.
2. Schmidt AH, Kyle RF. Periprosthetic fractures of the femur. Orthop Clin North Am 2002;33:143-52.
3. Bhattacharyya T, Chang D, Meigs JB, Estok DM 2nd, Malchau H. Mortality after periprosthetic fracture of the femur. J Bone Joint Surg Am 2007;89:2658-62.
4. Lindahl H, Oden A, Garellick G, Malchau H. The excess mortality due to periprosthetic femur fracture: a study from the Swedish national hip arthroplasty register. Bone 2007;40: 1294-8.
5. Sisto DJ, Lachiewicz PF, Insall JN. Treatment of supracondylar fractures following prosthetic arthroplasty of the knee. Clin Orthop Relat Res 1985;196:265-72.
6. McLaren AC, Dupont JA, Schroeber DC. Open reduction internal fixation of supracondylar fractures above total knee arthroplasties using the intramedullary supracondylar rod. Clin Orthop Relat Res 1994;302:194-8.
7. Hirsh DM, Bhalla S, Roffman M. Supracondylar fracture of the femur following total knee replacement: report of four cases. J Bone Joint Surg Am 1981;63:162-3.
8. Meek RM, Norwood T, Smith R, Brenkel IJ, Howie CR. The risk of peri-prosthetic fracture after primary and revision total hip and knee replacement. J Bone Joint Surg Br 2011;93:96-101.
9. Merkel KD, Johnson EW Jr. Supracondylar fracture of the femur after total knee arthroplasty. J Bone Joint Surg Am 1986;68:29-43.
10. Cain PR, Rubash HE, Wissinger HA, McClain EJ. Periprosthetic femoral fractures following total knee arthroplasty. Clin Orthop Relat Res 1986;208:205-14.
11. Shawen SB, Belmont PJ Jr, Klemme WR, Topoleski LD, Xenos JS, Orchowski JR. Osteoporosis and anterior femoral notching in periprosthetic supracondylar femoral fractures: a biomechanical analysis. J Bone Joint Surg Am 2003;85-A:115-21.
12. Berry DJ, Kessler M, Morrey BF. Maintaining a hip registry for 25 years: Mayo Clinic experience. Clin Orthop Relat Res 1997; 344:61-8.
13. Singh JA, Gabriel S, Lewallen D. The impact of gender, age, and preoperative pain severity on pain after TKA. Clin Orthop Relat Res 2008;466:2717-23.
14. Alden KJ, Duncan WH, Trousdale RT, Pagnano MW, Haidukewych GJ. Intraoperative fracture during primary total knee arthroplasty. Clin Orthop Relat Res 2010;468:90-5.
15. Parvizi J, Ereth MH, Lewallen DG. Thirty-day mortality following hip arthroplasty for acute fracture. J Bone Joint Surg Am 2004;86-A:1983-8.
16. Ortiguera CJ, Berry DJ. Patellar fracture after total knee arthroplasty. J Bone Joint Surg Am 2002;84-A:532-40.
17. Lewallen DG, Berry DJ. Periprosthetic fracture of the femur after total hip arthroplasty: treatment and results to date. Instr Course Lect 1998;47:243-9.
18. Peterson CA, Lewallen DG. Periprosthetic fracture of the acetabulum after total hip arthroplasty. J Bone Joint Surg Am 1996;78:1206-13.
19. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40: 373-83.
20. Charlson ME, Sax FL, MacKenzie CR, Braham RL, Fields SD, Douglas RG Jr. Morbidity during hospitalization: can we predict it? J Chronic Dis 1987;40:705-12.
21. World Health Organization. Obesity: preventing and managing the global epidemic. Geneva: World Health Organization; 2000.
22. Dripps RD, Lamont A, Eckenhoff JE. The role of anesthesia in surgical mortality. JAMA 1961;178:261-6.
23. Weaver F, Hynes D, Hopkinson W, Wixson R, Khuri S, Daley J, et al. Preoperative risks and outcomes of hip and knee arthroplasty in the Veterans Health Administration. J Arthroplasty 2003;18:693-708.
24. Yang YX, Lewis JD, Epstein S, Metz DC. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA 2006; 296:2947-53.
25. Targownik LE, Lix LM, Metge CJ, Prior HJ, Leung S, Leslie WD. Use of proton pump inhibitors and risk of osteoporosisrelated fractures. CMAJ 2008;179:319-26.
26. Vestergaard P, Rejnmark L, Mosekilde L. Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture. Calcif Tissue Int 2006; 79:76-83.
27. Gonnelli S, Caffarelli C, Maggi S, Guglielmi G, Siviero P, Rossi S, et al. Effect of inhaled glucocorticoids and (2) agonists on vertebral fracture risk in COPD patients: the EOLO study. Calcif Tissue Int 2010;87:137-43.
28. Lee TA, Weiss KB. Fracture risk associated with inhaled corticosteroid use in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004;169:855-9.
29. Pujades-Rodriguez M, Smith CJ, Hubbard RB. Inhaled corticosteroids and the risk of fracture in chronic obstructive pulmonary disease. QJM 2007;100:509-17.